Microbot Medical expands LIBERTY Robotic System commercial rollout
The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts
The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
The initiative pairs consumer engagement with a public health message about prevention and early detection
Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
New Centre of Excellence at Electronic City campus to offer specialised care in epilepsy, cerebrovascular disorders, neurointervention, skull base and spine surgery
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
The company’s Growth Portfolio delivered $6.2 billion in revenue
Lifts full-year outlook as obesity drug boom accelerates
Subscribe To Our Newsletter & Stay Updated